CLBAX
Price
$38.85
Change
-$0.10 (-0.26%)
Updated
Oct 7 closing price
Net Assets
266.1B
DDDRX
Price
$16.10
Change
-$0.04 (-0.25%)
Updated
Oct 7 closing price
Net Assets
845.73M
Interact to see
Advertisement

CLBAX vs DDDRX

Header iconCLBAX vs DDDRX Comparison
Open Charts CLBAX vs DDDRXBanner chart's image
American Funds American Balanced 529A
Price$38.85
Change-$0.10 (-0.26%)
VolumeN/A
Net Assets266.1B
Macquarie Wealth Builder R
Price$16.10
Change-$0.04 (-0.25%)
VolumeN/A
Net Assets845.73M
CLBAX vs DDDRX Comparison Chart in %
View a ticker or compare two or three
VS
CLBAX vs. DDDRX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Hold and DDDRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 266B vs. DDDRX (846M). CLBAX pays higher dividends than DDDRX: CLBAX (1.76) vs DDDRX (1.27). CLBAX was incepted earlier than DDDRX: CLBAX (24 years) vs DDDRX (22 years). DDDRX (1.34) is less costly to investors than CLBAX (0.58). DDDRX is a more actively managed with annual turnover of: 66.00 vs. CLBAX (44.00). DDDRX has a lower initial minimum investment than CLBAX: DDDRX (0) vs CLBAX (250). CLBAX annual gain was more profitable for investors over the last year : 9.98 vs. DDDRX (5.40). CLBAX return over 5 years is better than : 44.30 vs. DDDRX (31.01).
CLBAXDDDRXCLBAX / DDDRX
Total Expense Ratio0.581.3144%
Annual Report Gross Expense Ratio0.581.3443%
Fund Existence24 years22 years-
Gain YTD14.42010.717135%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets266B846M31,442%
Annual Yield % from dividends1.761.27138%
Returns for 1 year9.985.40185%
Returns for 3 years51.8628.18184%
Returns for 5 years44.3031.01143%
Returns for 10 years89.1640.95218%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTR5.10N/A
+0.08%
Mesa Royalty Trust
SUPN48.07-0.24
-0.50%
Supernus Pharmaceuticals
COHR113.56-1.21
-1.05%
Coherent Corp
ABOS1.88-0.06
-3.09%
Acumen Pharmaceuticals
CINT4.58-0.40
-8.03%
CI&T